EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.22.70 | medicine | 4-vinylsulfonyl 5-phenyl prolinates inhibit Staphylococcus aureus sortase SrtA irreversibly by modification of the enzyme Cys184 and could be used as hits for the development of antibacterials and antivirulence agents | Staphylococcus aureus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.4.22.70 | N-terminally His6-tagged SrtA lacking the amino-terminal 24 amino acids is expressed in BL21(DE3) cells containing the plasmid pET15bSrtADN24 | Staphylococcus aureus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.22.70 | methyl (2S,3S,7aS)-2-ethenesulfonyl-5-oxo-3-phenyltetrahydropyrrolizine-7a-carboxylate | - |
Staphylococcus aureus | |
3.4.22.70 | methyl (2S,3S,7aS)-2-ethenesulfonyl-5-oxo-3-pyridin-3-yl-tetrahydropyrrolizine-7a-carboxylate | - |
Staphylococcus aureus | |
3.4.22.70 | methyl (2S,3S,7aS)-3-(3,4-dimethoxyphenyl)-2-ethenesulfonyl-5-oxotetrahydropyrrolizine-7a-carboxylate | - |
Staphylococcus aureus | |
3.4.22.70 | methyl (2S,4S,5S)-4-ethenesulfonyl-2-(2-methoxycarbonylethyl)-5-pyridin-3-yl-pyrrolidine-2-carboxylate | - |
Staphylococcus aureus | |
3.4.22.70 | methyl (4S,5S)-4-(ethenylsulfonyl)-5-(2-fluorophenyl)-L-prolinate | - |
Staphylococcus aureus | |
3.4.22.70 | methyl (4S,5S)-4-(ethenylsulfonyl)-5-(3-fluorophenyl)-L-prolinate | - |
Staphylococcus aureus | |
3.4.22.70 | methyl (4S,5S)-4-(ethenylsulfonyl)-5-phenyl-L-prolinate | - |
Staphylococcus aureus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.22.70 | Staphylococcus aureus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.22.70 | recombinant SrtA lacking the amino-terminal 24 amino acids | Staphylococcus aureus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.22.70 | Abz-LPETG-Dap(Dnp)-NH2 + Gly5 | transpeptidation of LPXTG-containing peptides to the cell-wall precursor mimic NH2-Ala2 | Staphylococcus aureus | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.22.70 | sortase SrtA | - |
Staphylococcus aureus |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.4.22.70 | 0.85 | - |
pH 7.5, 37°C | Staphylococcus aureus | methyl (4S,5S)-4-(ethenylsulfonyl)-5-phenyl-L-prolinate | |
3.4.22.70 | 1.04 | - |
pH 7.5, 37°C | Staphylococcus aureus | methyl (4S,5S)-4-(ethenylsulfonyl)-5-(3-fluorophenyl)-L-prolinate | |
3.4.22.70 | 1.32 | - |
pH 7.5, 37°C | Staphylococcus aureus | methyl (4S,5S)-4-(ethenylsulfonyl)-5-(2-fluorophenyl)-L-prolinate | |
3.4.22.70 | 1.86 | - |
pH 7.5, 37°C | Staphylococcus aureus | methyl (2S,4S,5S)-4-ethenesulfonyl-2-(2-methoxycarbonylethyl)-5-pyridin-3-yl-pyrrolidine-2-carboxylate | |
3.4.22.70 | 2.2 | - |
pH 7.5, 37°C | Staphylococcus aureus | methyl (2S,3S,7aS)-2-ethenesulfonyl-5-oxo-3-phenyltetrahydropyrrolizine-7a-carboxylate | |
3.4.22.70 | 2.47 | - |
pH 7.5, 37°C | Staphylococcus aureus | methyl (2S,3S,7aS)-2-ethenesulfonyl-5-oxo-3-pyridin-3-yl-tetrahydropyrrolizine-7a-carboxylate | |
3.4.22.70 | 2.68 | - |
pH 7.5, 37°C | Staphylococcus aureus | methyl (2S,3S,7aS)-3-(3,4-dimethoxyphenyl)-2-ethenesulfonyl-5-oxotetrahydropyrrolizine-7a-carboxylate |